Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.

BACKGROUND AND PURPOSE: Overexpression or aberrant activation of the T‐lymphokine‐activated killer cell‐originated protein kinase (TOPK) promotes gene expression and growth of solid tumours, implying that TOPK would be a rational target in developing novel anticancer drugs. Acetylshikonin, a diterpe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Zhao, Ran, Choi, Bu Young, Wei, Lixiao, Fredimoses, Mangaladoss, Yin, Fanxiang, Fu, Xiaorong, Chen, Hanyong, Liu, Kangdong, Kundu, Joydeb Kumar, Dong, Zigang, Lee, Mee‐Hyun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174886/
https://ncbi.nlm.nih.gov/pubmed/31985814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados